Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 192, 226-231
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of ratsNeuropharmacology, 2012
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for TreatmentNeuropsychopharmacology, 2011
- Clozapine, but not haloperidol, enhances gliald‐serine and L‐glutamate release in rat frontal cortex and primary cultured astrocytesBritish Journal of Pharmacology, 2011
- Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature ReviewSchizophrenia Bulletin, 2011
- Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysisMolecular Psychiatry, 2010
- Results of phase 3 of the CATIE schizophrenia trialSchizophrenia Research, 2009
- Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorderNeuroscience Letters, 2007
- Plasma Concentrations of Amino Acids in Chronic Schizophrenics Treated with ClozapineNeuropsychobiology, 2001
- Clozapine treatment increases serum glutamate and aspartate compared to conventional neurolepticsJournal of Neural Transmission, 1997
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993